Foto del docente

Roberto Rimondini Giorgini

Associate Professor

Department of Medical and Surgical Sciences

Academic discipline: BIO/14 Pharmacology

Publications

vai alle Pubblicazioni

Publications prior to 2004

1.       Rimondini R , Sommer W, Heilig M. “A temporal threshold for induction of persistent alcohol preference: behavioural evidence in a rat model of intermittent intoxication.” J STUD ALCOHOL. 2003 Jul; 64(4):445-9.

2.       Hansson AC, Sommer W, Rimondini R, Andbjer B, Stromberg I, Fuxe K. “c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region.” J NEUROSCI. 2003 Jul 9; 23(14):6013-22.

3.       Kela J, Salmi P, Rimondini R, Heilig M, Wahlestedt C. “Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties.” REGUL PEPT. 2003 Jul 15;114(2-3):109-14.

4.       Rimondini R , Agren G, Borjesson S, Sommer W, Heilig M. “Persistent behavioral and autonomic supersensitivity to stress following prenatal stress exposure in rats.” BEHAV BRAIN RES. 2003 Mar 18; 140(1-2):75-80.

5.       Thorsell A, Rimondini R, Heilig M. “Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats.” NEUROSCI LETT 2002 Oct 25; 332(1):1-4.

6.       Rimondini R , Sommer W, Heilig M. “Effects of tiagabine and diazepam on operant ethanol self-administration in the rat.” J STUD ALCOHOL. 2002 Jan; 63(1):100-6.

7.       Moller C, Sommer W, Thorsell A, Rimondini R, Heilig M. “Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test.” PROG NEUROPSYCHOPHARMACOL BIOL PSYCHIATRY 2002 Jan; 26(1):119-22.

8.       Thorsell A, Caberlotto L, Rimondini R, Heilig M. “Leptin suppression of hypothalamic NPY expression and feeding, but not amygdale NPY expression and experimental anxiety.” PHARMACOL BIOCHEM BEHAV. 2002 Mar;71(3):425-30.

9.       Rimondini R , Arlinde C, Sommer W, Heilig M. “Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol.” FASEB J. 2002 Jan; 16(1):27-35.

10.    Caberlotto L, Thorsell A, Rimondini R, Sommer W, Hyytia P, Heilig M. “Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats.” ALCHOL CLIN EXP RES. 2001 Nov; 25(11):1564-9.

11.    Ferre S, Popoli P, Gimenez-Llort L, Rimondini R, Muller CE, Stromberg I, Ogren SO, Fuxe K. “Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease.” PARKINSONISM RELAT DISORD. 2001 Jul; 7(3):235-241.

12.    Sommer W, Moller C, Wiklund L, Thorsell A, Rimondini R, Nissbrandt H, Heilig M. “Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption.” NEUROPSYCHOPHARMACOLOGY 2001 Apr; 24 (4):430-40.

13.    Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M. “Behavioral insensitivity to restraint stress, absent fear suppression of behaviour  and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.” Proc Natl Acad Sci U S A. 2000 Nov 7; 97(23):12852-7.

14.    Ferre S, Rimondini R, Popoli P, Reggio R, Pezzola A, Hansson AC, Andersson A, Fuxe K. “Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.” EUR J NEUROSCI. 1999 Nov;11(11):3884-92.

15.    Rimondini R , Fuxe K, Ferre S. “Multiple intramembrane receptor-receptor interactions in the regulation of striatal dopamine D2 receptors.” NEUROREPORT 1999 Jul 13;10(10):2051-4.

16.    Ferre S, Popoli P, Rimondini R, Reggio R, Kehr J, Fuxe K. “Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.” NEUROPHARMACOLOGY 1999 Jan; 38(1):129-40.

17.    Misane I, Klusa V, Dambrova M, Germane S, Duburs G, Bisenieks E, Rimondini R, Ogren SO. "Atypical" neuromodulatory profile of glutapyrone, a representative of a novel'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies.” EUR NEUROPSYCHOPHARMACOL. 1998 Dec; 8(4):329-47.

18.    Rimondini R , Ferre S, Gimenez-Llort L, Ogren SO, Fuxe K. “Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.” EUR J PHARMACOL 1998 Apr 24; 347(2-3):153-8.

19.    Popoli P, Betto P, Rimondini R, Reggio R, Pezzola A, Ricciarello G, Fuxe K, Ferre S. “Age-related alteration of the adenosine/dopamine balance in the rat striatum.” BRAIN RES. 1998 Jun 8; 795(1-2):297-300.

20.    Dall'Olio R, Rimondini R, Gandolfi O. “Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH DPAT and quinpirole in rats.” PHARMACOL RES. 1997 Sep; 36(3):203-9.

21.    Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP. “Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.” NATURE 1998 Jan 8; 391(6663):173-7.

22.    Rimondini R , Ferre S, Ogren SO, Fuxe K. “Adenosine A2A agonists: a potential new type of atypical antipsychotic.” NEUROPSYCHOPHARMACOLOGY 1997 Aug; 17(2):82-91.

23.    Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. “Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia.” NEUROREPORT 1997 Jul 28; 8(11):2623-9.

24.    Sommer W, Rimondini R, O'Connor W, Hansson AC, Ungerstedt U, Fuxe K. “Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat.” PROC NATL ACAD SCI U S A. 1996 Nov 26; 93(24):14134-9.

25.    Ferraro L, O'Connor WT, Li XM, Rimondini R, Beani L, Ungerstedt U, Fuxe K, Tanganelli S. “Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms.” NEUROSCIENCE 1996 Aug; 73(4):941-50.

26.    Rimondini R , O'Connor WT, Sillard R, Mutt V, Ungerstedt U, Fuxe K. “The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study.” REGUL PEPT. 1996 Feb 22; 61(2):111-7.

27.    Dall'Olio R, Rimondini R, Gandolfi O. “Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.” PSYCHOPHARMACOLOGY (Berl) 1996 Jan; 123(2):187-90.

28.    Dall'Olio R, Rimondini R, Gandolfi O. “The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.” PSYCHOPHARMACOLOGY (Berl) 1995 Apr; 118(3):310-5.

29.    Rimondini R , O'Connor WT, Ferre S, Sillard R, Agerberth B, Mutt V, Ungerstedt U, Fuxe K. “PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis study.” NEUROSCI LETT. 1994 Aug 15; 177(1-2):53-7.

30.    Gandolfi O, Rimondini R, Dall'Olio R. “D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain.” PHARMACOL BIOCHEM BEHAV. 1994 Jun; 48(2):351-6.

31.    Gandolfi O, Dall'Olio R, Rimondini R, Bongrani S, Valsecchi B. “Repeated administrations of (-)-deprenyl increase [3H]MK801 binding in rat brain and antagonize the impairment of passive avoidance conditioning induced by -methyl-D-aspartate receptor antagonists.” NEUROSCI LETT. 1994 Jan 3;165(1-2):113-6.

32.    Dall'Olio R, Rimondini R, Gandolfi O. “The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat.” NEUROPHARMACOLOGY 1994 Jan; 33(1):55-9.

33.    Gandolfi O, Rimondini R, Dall'Olio R. “The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.” NEUROPHARMACOLOGY 1992 Nov; 31(11):1111-4.

Review

1.       Fuxe K, Stromberg I, Popoli P, Rimondini R, Torvinen M, Ogren SO, Franco R, Agnati LF, Ferre S. “Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.” ADV NEUROL. 2001;86:345-53. Review.